When anti-IL-17A Ab was injected i.p. into mice daily for 6 days, beginning from 24 h post-RRV infection, compared with RRV-primed mice without anti-IL-17A Ab injection, the survival rate was increased and weight gain was improved (S3 Fig). The gene discussed is IL17A; the disease is infection.